News | May 07, 2023
Lupin to acquire French pharmaceutical company Medisol
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
New agreement applies to the polymers of the Medical Care series portfolio
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
The business and product range of Ipca and that of Unichem complements each others business and product range
Subscribe To Our Newsletter & Stay Updated
